2026³â 03¿ù 26ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Business

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

Rigaku Completes New Building at Yamanashi Plant

Dramatic 2.7-fold increase in floor space to serve global demand
´º½ºÀÏÀÚ: 2025-08-07


Exterior view of the New Building, Yamanashi Plant

TOKYO -- Rigaku Corporation, a global solution partner in X-ray analytical technologies and a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; President and CEO: Jun Kawakami; hereinafter “Rigaku”) completed an additional manufacturing building (hereinafter “the New Building”) at Yamanashi Plant, Rigaku’s main production facility. The facility was established to serve as the center of Rigaku’s production framework, in anticipation of global business growth and expansion in product demand.

Doubling of production capacity: a strategic base to support Rigaku’s growth

Demand for X-ray analytical solutions has soared in recent years, both in Japan and worldwide. To respond to growing demand, Rigaku implemented this expansion with two key objectives in mind.

One objective is to further reinforce the Company’s ability to serve the needs of rapidly growing fields such as semiconductors and electronic components; batteries and battery materials; and life sciences. The other objective is to dramatically expand Rigaku’s production capacity for the components that support the Company’s product lineup generally. The components are the crystallization of Rigaku’s core technologies and the wellspring of its competitive strength.
To accomplish the two objectives described above, Rigaku plans to double its overall manufacturing capacity by 2027 (compared with 2022, unit basis). Rigaku aims to achieve this goal by expanding production space, through the construction of the New Building at Yamanashi Plant in addition to the expansion provided by Osaka Plant and external partners, and by shortening lead time to reinforce its supply chain.

Yamanashi Plant: Advancing as a Comprehensive Manufacturing Base

With the New Building’s completion, Yamanashi Plant’s floor space has expanded dramatically, almost tripling (2.7x) from 8,500 sqm to 23,000 sqm. Processes for manufacturing, assembly and shipping of X-ray diffraction systems, formerly distributed between Yamanashi and Tokyo, are now concentrated in spacious Yamanashi Plant, delivering a quantum leap in operational efficiency and ensuring stable supply of high-quality products.

Rigaku is also advancing proving tests for automation of production processes at Yamanashi Plant. The Company’s aim is to transform the Plant into a “smart factory” that achieves excellence in both efficiency and quality.

An eco-friendly “plant in harmony with nature”

Rigaku used eco-friendly construction methods to erect the New Building, taking care to reduce CO2 emissions. To minimize energy waste, the facility is outfitted with high-efficiency equipment and solar-power generation systems. The New Building is a “plant in harmony with nature,” contributing to the achievement of a sustainable society by reducing environmental impact.

Jun Kawakami, President and CEO of Rigaku, offered the following comment:
With this major floor space expansion, Rigaku is boosting manufacturing capacity and enhancing product quality to support its substantial growth. It also strengthens our ability to produce the components of our products, which are the foundation of Rigaku's competitive advantage. This facility is the key to ensuring that our existing customers continue to choose Rigaku, as well as helping Rigaku acquire new customers globally.

The New Building is slated to begin operation in early June, gradually strengthening Rigaku’s production framework.



 Àüü´º½º¸ñ·ÏÀ¸·Î

Galderma¡¯s Nemluvio¢ç (nemolizumab) Demonstrates Long-Term Disease Control in Prurigo Nodularis up to Three Years
Venture Global Announces LNG Purchase Agreement with Trafigura
Flexitech Chooses Rimini Street to Extend the Life of its SAP ECC, Accelerate Compliance and Fund Innovation
3650 Capital Wins PERE Credit Alternative Lender of the Year Award
¡°YOUR ONE AND ONLY. Biore Global Brand Event¡± Held in Seongsu, South Korea
Boomi Named 12X Leader, Highest Execution in 2026 Gartner Magic Quadrant for iPaaS
Andersen Consulting Broadens Built-Asset Advisory Through Collaboration with Grinity

 

Andersen Consulting Expands Capabilities with Assure Consulting
Yubico Unveils ¡°YubiNation Partners¡±: A New Era of Global Channel Pa...
Industrial Decarbonization: Calderion, WenCo and Terravent Invest in G...
Morocco¡¯s FRMF Welcomes CAF Appeal Board as Upholding Rules, Stabilit...
Newmont Reports 2025 Mineral Reserves of 118.2 Million Gold Ounces and...
KleanNara Partners with Rimini Street to Accelerate Digital Transforma...
INNIO signs Definitive Agreement to Acquire Enerflex APAC Operations, ...

 


°øÁö»çÇ×
´º½ºÁö Áß¹®Ç¥±â´Â À½Â÷ Ç¥±â¹æ½Ä '纽ÞÙó¢ ´Ï¿ì½ÃÁö'
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬银öõ(ÜÄÒ¬ÜØ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®À¯ºñ Alliuv ä¹备: ä¹êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..